Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Treasury Shares (2021 - 2025)

Treace Medical Concepts' Treasury Shares history spans 3 years, with the latest figure at $1.2 million for Q4 2025.

  • For Q4 2025, Treasury Shares rose 321.0% year-over-year to $1.2 million; the TTM value through Dec 2025 reached $1.2 million, up 321.0%, while the annual FY2025 figure was $1.2 million, 321.0% up from the prior year.
  • Treasury Shares reached $141572.0 in Q3 2025 per TMCI's latest filing, up from $77890.0 in the prior quarter.
  • In the past five years, Treasury Shares ranged from a high of $4.4 million in Q4 2024 to a low of $12800.0 in Q4 2022.
  • Average Treasury Shares over 5 years is $447269.8, with a median of $19604.0 recorded in 2024.
  • Peak YoY movement for Treasury Shares: surged 2061.54% in 2024, then soared 172.8% in 2025.
  • A 3-year view of Treasury Shares shows it stood at $13000.0 in 2023, then soared by 2061.54% to $281000.0 in 2024, then soared by 321.0% to $1.2 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Treasury Shares are $1.2 million (Q4 2025), $1.1 million (Q3 2025), and $696000.0 (Q2 2025).